Information Provided By:
Fly News Breaks for August 28, 2019
MD
Aug 28, 2019 | 05:14 EDT
Mizuho analyst Ann Hynes says that given the headwinds in its base business, she now expects a continued low level of acquisition activity for Mednax not just in 2019, but also in 2020. The analyst lowered her 2020 adjusted EBITDA estimate to $505M from $523M, below the consensus at $513M. She also dropped her price target for the shares to $23 from $24 and keeps a Neutral rating on Mednax.
News For MD From the Last 2 Days
MD
Dec 11, 2019 | 16:38 EDT
The Federal Reserve did just what was expected and the market took it as a mild positive. The central bank's... To see the rest of the story go to thefly.com. See Story Here
MD
Dec 11, 2019 | 12:08 EDT
Stocks are having another quiet morning as investors wait for the Federal Reserve to wrap up its last rate setting meeting of the year. There are virtually... To see the rest of the story go to thefly.com. See Story Here